Pediatric drug formulations of sodium benzoate: II. Coated granules with a lipophilic binder

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 56, Issue 2, 2003, Pages 255-260

  Breitkreutz, Jörg ^a   El Saleh, Firas ^b   Kiera, Christian ^b   Kleinebudde, Peter ^c   Wiedey, Wolfgang ^b,d  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Pharbil GmbH   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Ethicare GmbH   (Germany)

Author keywords

Cold extrusion; Microencapsulation; Orphan drugs; Pediatric formulations; Polymethacrylate; Sodium benzoate; Solvent free granulation; Triglycerides

Indexed keywords

ALCOHOL; BENZOIC ACID; CITRIC ACID TRIETHYL ESTER; EUDRAGIT; GLYCEROL PALMITOSTEARATE; MACROGOL DERIVATIVE; METHACRYLIC ACID DERIVATIVE; ORPHAN DRUG; POLYMER; SILICON DIOXIDE; STEARIC ACID DERIVATIVE; SYLOID; TRIACYLGLYCEROL;

ARTICLE; DRUG COATING; DRUG GRANULATION; DRUG INDICATION; DRUG SOLUBILITY; DRUG STABILITY; FLUIDIZED BED; HYPERGLYCINEMIA; LIPOPHILICITY; MICROCAPSULE; MICROENCAPSULATION; PELLET EXTRUSION; PHARMACEUTICAL ENGINEERING; ROOM TEMPERATURE; SPHERONIZATION;

EID: 0043142380     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(03)00090-0     Document Type: Article

References (10)

1. Van Hove J.L.K., Kishnani P., Muenzer J., Wenstrup R.J., Summar M.L., Brummond M.R., Lachiewicz A.M., Millington D.S., Kahler S.G. Benzoate therapy and carnithine deficiency in non-ketotic hyperglycinemia. Am. J. Med. Gen. 59:1995;444-453.
2. Green T.P., Marchessault R.P., Freese D.K. Disposition of sodium benzoate in newborn infants with hyperammonemia. J. Pediatr. 102:1983;785-790.
3. Breitkreutz J., Wessel T., Boos J. Dosage forms for peroral drug administration to children. Paediatr. Perin. Drug Ther. 3:1999;25-33.
4. J. Breitkreutz, M. Bornhöft, F. Wöll, P. Kleinebudde, Pediatric drug formulations of sodium benzoate: I. Coated granules with a hydrophilic binder, Eur. J. Pharm. Biopharm. 56 (2003) d.o.i. 10.1016/S0939-6411(03)00091-2.
5. European Agency for the Evaluation of Medicinal Products (EMEA), Clinical investigation of medicinal products in the paediatric population (CPMP/ICH/211/99).
6. Joint Expert Committee for Food Additives (JECFA), www.inchem.org/pages/jecfa.html.
7. Voinovich D., Moneghini M., Perissutti B., Franceschinis E. Melt pelletization in high shear mixer using a hydrophobic melt binder: influence of some apparatus and process variables. Eur. J. Pharm. Biopharm. 52:2001;305-313.
8. Knop K. Influence of buffer solution composition on drug release from pellets coated with neutral and quarternary acrylic polymers and on swelling of free polymer films. Eur. J. Pharm. Sci. 4:1996;293-300.
9. Bodmeier R., Guo X., Sarabia E.E., Skultety P.F. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30 D. Pharm. Res. 13:1996;52-56.
10. Wagner K.G. Mechanisms of ionic interactions between dissolution medium an a cationic PMMA film. Arch. Pharm. Pharm. Med. 334:(Suppl.2):2001;23.